Future CFO

SEPTEMBER 19, 2023

18 released its final recommendations on nature-related risk management and disclosure, aligned with existing Global Reporting Initiative (GRI) and International Financial Reporting Standards (IFRS) and Kunming-Montreal Biodiversity Framework requirements. The Taskforce on Nature-related Financial Disclosures on Sept.

Risk Management 52

Risk Management IFRS Pharmaceutical Economics 52

CFO Talks

SEPTEMBER 30, 2024

Similarly the South African Financial Reporting Standards Council (FRSC) has adopted a blanked adoption approach to IFRS and IAS with very little effort to consider if the standards will contribute to local economic growth and employment. As a developing nation, we cannot afford to stifle our innovation.

Accounting Standards 98

Accounting Standards Economics IFRS Auditing 98

CFO Talks

OCTOBER 2, 2024

The research “How to improve IFRS for intangible assets? Share price : Without a clear reflection of R&D and innovation, the market capitalization could remain lower than it should be, especially for companies in technology, pharmaceuticals, and other high-growth sectors.

Accounting 98

Accounting CFO Economics Accounting Standards 98

CFO News Room

JANUARY 18, 2023

IFRS and GAAP now treat as leases as debt, but that is still not the case in many other markets that are not covered by either standard). The numbers yield interesting insights. .

Marketing 130

Marketing Hurdle Rate Investments Accounting 130

Musings on Markets

FEBRUARY 27, 2022

IFRS and GAAP now treat as leases as debt, but that is still not the case in many other markets that are not covered by either standard). The numbers yield interesting insights.

Hurdle Rate 82

Hurdle Rate Investments Accounting Entertainment 82

Musings on Markets

OCTOBER 6, 2023

Even a cursory examination of the the Nifty Fifty , the stocks that drove US equities upwards in the early 1970s, reveals companies like Coca Cola and Gilette, where brand name was a significant contributor to value, as well as pharmaceutical companies like Bristol-Myers and Pfizer, which derived a large portion of their value from patents.

Valuation 106

Valuation Profit and Loss Accounting Investments 106